organization · Reporting owner
LILLY ENDOWMENT INC
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ELI LILLY & Co
Report date May 06, 2026 · Filed May 07, 2026
Section 16 reporting ended · disclosed 2026-05-07. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 91,881,150 |
Ending reported balance
After 2026-05-06 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-05-06 · Sale · Disposed 13,620 · Balance 91,883,358 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $995.00 to $995.9963, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) and (2) to this Form 4. Row 2 · 2026-05-06 · Sale · Disposed 2,208 · Balance 91,881,150 F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $996.00 to $996.46, inclusive. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $995.00 to $995.9963, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) and (2) to this Form 4.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $996.00 to $996.46, inclusive.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 21, 2022 Filed Oct 24, 2022 20:10 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 41,571 | $338.49 | $14,071,326.22 |
DisclosureSEC source: 0001209191-22-054393 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,419,045 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $338.02 to $339.01, inclusive. Read SEC document |
| October 21, 2022 Filed Oct 24, 2022 20:10 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 14,987 | $337.30 | $5,055,085.13 |
DisclosureSEC source: 0001209191-22-054393 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,460,616 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $337.00 to $337.96, inclusive. Read SEC document |
| October 21, 2022 Filed Oct 24, 2022 20:10 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 13,512 | $336.52 | $4,547,017.70 |
DisclosureSEC source: 0001209191-22-054393 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,475,603 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $336.00 to $336.99, inclusive. Read SEC document |
| October 21, 2022 Filed Oct 24, 2022 20:10 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 36,631 | $335.27 | $12,281,312.00 |
DisclosureSEC source: 0001209191-22-054393 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,489,115 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $335.00 to $335.975, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), and (8) to this Form 4. Read SEC document |
| October 19, 2022 Filed Oct 20, 2022 18:17 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 3,547 | $335.48 | $1,189,933.37 |
DisclosureSEC source: 0001209191-22-054178 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,525,746 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $335.19 to $335.55, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| October 18, 2022 Filed Oct 19, 2022 18:56 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 3,966 | $335.04 | $1,328,764.67 |
DisclosureSEC source: 0001209191-22-054056 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,529,293 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $334.58 to $335.33, inclusive. Read SEC document |
| October 18, 2022 Filed Oct 19, 2022 18:56 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 8,076 | $333.53 | $2,693,612.51 |
DisclosureSEC source: 0001209191-22-054056 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,533,259 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $333.50 to $334.425, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| October 17, 2022 Filed Oct 18, 2022 19:45 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 400 | $337.56 | $135,024.00 |
DisclosureSEC source: 0001209191-22-053950 · doc4.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,541,335 Read SEC document |
| October 17, 2022 Filed Oct 18, 2022 19:45 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 16,217 | $336.96 | $5,464,480.32 |
DisclosureSEC source: 0001209191-22-053950 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,541,735 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $336.52 to $337.515, inclusive. Read SEC document |
| October 17, 2022 Filed Oct 18, 2022 19:45 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 18,716 | $336.02 | $6,288,856.74 |
DisclosureSEC source: 0001209191-22-053950 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,557,952 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $335.52 to $336.51, inclusive. Read SEC document |
| October 17, 2022 Filed Oct 18, 2022 19:45 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 26,044 | $335.13 | $8,728,151.76 |
DisclosureSEC source: 0001209191-22-053950 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,576,668 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $334.51 to $335.50, inclusive. Read SEC document |
| October 17, 2022 Filed Oct 18, 2022 19:45 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 18,247 | $333.76 | $6,090,118.72 |
DisclosureSEC source: 0001209191-22-053950 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,602,712 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $333.50 to $334.49, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3) and (4) to this Form 4. Read SEC document |
| October 14, 2022 Filed Oct 17, 2022 17:02 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 487 | $335.08 | $163,184.45 |
DisclosureSEC source: 0001209191-22-053758 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,620,959 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $334.815 to $335.26, inclusive. Read SEC document |
| October 14, 2022 Filed Oct 17, 2022 17:02 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 2,700 | $333.75 | $901,122.30 |
DisclosureSEC source: 0001209191-22-053758 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,621,446 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $333.50 to $334.10, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| October 12, 2022 Filed Oct 13, 2022 21:36 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 400 | $333.50 | $133,400.40 |
DisclosureSEC source: 0001209191-22-053587 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,624,146 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $333.50 to $333.505, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| October 06, 2022 Filed Oct 7, 2022 19:08 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 2,100 | $338.94 | $711,771.90 |
DisclosureSEC source: 0001209191-22-053073 · doc4.xml · nonDerivative · entry 6 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,624,546 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $338.67 to $339.12, inclusive. Read SEC document |
| October 06, 2022 Filed Oct 7, 2022 19:08 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 3,500 | $338.44 | $1,184,533.00 |
DisclosureSEC source: 0001209191-22-053073 · doc4.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,626,646 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $337.64 to $338.58, inclusive. Read SEC document |
| October 06, 2022 Filed Oct 7, 2022 19:08 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 5,400 | $337.12 | $1,820,453.40 |
DisclosureSEC source: 0001209191-22-053073 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,630,146 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $336.58 to $337.50, inclusive. Read SEC document |
| October 06, 2022 Filed Oct 7, 2022 19:08 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 8,600 | $335.96 | $2,889,256.00 |
DisclosureSEC source: 0001209191-22-053073 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,635,546 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $335.50 to $336.33, inclusive. Read SEC document |
| October 06, 2022 Filed Oct 7, 2022 19:08 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 30,746 | $335.00 | $10,299,940.75 |
DisclosureSEC source: 0001209191-22-053073 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,644,146 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $334.50 to $335.495, inclusive. Read SEC document |
| October 06, 2022 Filed Oct 7, 2022 19:08 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 98,918 | $333.89 | $33,028,126.69 |
DisclosureSEC source: 0001209191-22-053073 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,674,892 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $333.50 to $334.49, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5) and (6) to this Form 4. Read SEC document |
| September 28, 2022 Filed Sep 29, 2022 17:56 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 300 | $340.85 | $102,253.50 |
DisclosureSEC source: 0001209191-22-051511 · doc4.xml · nonDerivative · entry 9 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,773,810 F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $340.665 to $341.10, inclusive. Read SEC document |
| September 28, 2022 Filed Sep 29, 2022 17:56 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 1,175 | $340.01 | $399,512.93 |
DisclosureSEC source: 0001209191-22-051511 · doc4.xml · nonDerivative · entry 8 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,774,110 F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $339.6205 to $340.52, inclusive. Read SEC document |
| September 28, 2022 Filed Sep 29, 2022 17:56 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 4,718 | $339.00 | $1,599,416.15 |
DisclosureSEC source: 0001209191-22-051511 · doc4.xml · nonDerivative · entry 7 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,775,285 F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $338.54 to $339.535, inclusive. Read SEC document |
| September 28, 2022 Filed Sep 29, 2022 17:56 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 9,189 | $338.00 | $3,105,872.81 |
DisclosureSEC source: 0001209191-22-051511 · doc4.xml · nonDerivative · entry 6 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,780,003 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $337.54 to $338.53, inclusive. Read SEC document |
| September 28, 2022 Filed Sep 29, 2022 17:56 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 7,525 | $337.05 | $2,536,323.83 |
DisclosureSEC source: 0001209191-22-051511 · doc4.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,789,192 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $336.54 to $337.53, inclusive. Read SEC document |
| September 28, 2022 Filed Sep 29, 2022 17:56 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 10,197 | $336.11 | $3,427,293.28 |
DisclosureSEC source: 0001209191-22-051511 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,796,717 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $335.54 to $336.535, inclusive. Read SEC document |
| September 28, 2022 Filed Sep 29, 2022 17:56 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 15,116 | $334.84 | $5,061,486.79 |
DisclosureSEC source: 0001209191-22-051511 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,806,914 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $334.5179 to $335.48, inclusive. Read SEC document |
| September 28, 2022 Filed Sep 29, 2022 17:56 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 32,080 | $334.21 | $10,721,360.56 |
DisclosureSEC source: 0001209191-22-051511 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,822,030 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $333.50 to $334.48, inclusive. Read SEC document |
| September 28, 2022 Filed Sep 29, 2022 17:56 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 21,331 | $332.86 | $7,100,130.01 |
DisclosureSEC source: 0001209191-22-051511 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,854,110 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $332.50 to $333.48, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), (8), and (9) to this Form 4. Read SEC document |
| July 28, 2022 Filed Jul 29, 2022 15:43 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 500 | $333.51 | $166,755.00 |
DisclosureSEC source: 0001209191-22-043434 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,875,441 Read SEC document |
| July 28, 2022 Filed Jul 29, 2022 15:43 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 88,958 | $332.85 | $29,609,759.26 |
DisclosureSEC source: 0001209191-22-043434 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,875,941 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $332.50 to $333.49 , inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| July 26, 2022 Filed Jul 27, 2022 14:26 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 1,601 | $332.52 | $532,370.92 |
DisclosureSEC source: 0001209191-22-043241 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,964,899 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $332.50 to $332.57, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| July 15, 2022 Filed Jul 18, 2022 17:50 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 720 | $335.24 | $241,372.80 |
DisclosureSEC source: 0001209191-22-042380 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,966,500 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $335.20 to $335.33, inclusive. Read SEC document |
| July 15, 2022 Filed Jul 18, 2022 17:50 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 571 | $334.15 | $190,800.79 |
DisclosureSEC source: 0001209191-22-042380 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,967,220 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $333.9357 to $334.4811, inclusive. Read SEC document |
| July 15, 2022 Filed Jul 18, 2022 17:50 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 16,019 | $332.60 | $5,327,839.31 |
DisclosureSEC source: 0001209191-22-042380 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,967,791 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $332.50 to $333.34, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4. Read SEC document |
| July 06, 2022 Filed Jul 7, 2022 16:03 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 2,428 | $332.23 | $806,642.30 |
DisclosureSEC source: 0001209191-22-041425 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,983,810 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $332.00 to $332.515, inclusive. Read SEC document |
| July 06, 2022 Filed Jul 7, 2022 16:03 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 43,875 | $331.33 | $14,536,884.38 |
DisclosureSEC source: 0001209191-22-041425 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,986,238 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $331.00 to $331.99, inclusive. Read SEC document |
| July 06, 2022 Filed Jul 7, 2022 16:03 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 52,138 | $330.42 | $17,227,594.37 |
DisclosureSEC source: 0001209191-22-041425 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,030,113 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $330.00 to $330.98, inclusive. Read SEC document |
| July 06, 2022 Filed Jul 7, 2022 16:03 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 78,802 | $329.54 | $25,968,174.67 |
DisclosureSEC source: 0001209191-22-041425 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,082,251 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $329.00 to $329.995, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3) and (4) to this Form 4. Read SEC document |
| June 28, 2022 Filed Jun 29, 2022 15:31 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 900 | $329.01 | $296,109.00 |
DisclosureSEC source: 0001209191-22-039724 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,161,053 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $329.00 to $329.055, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| June 27, 2022 Filed Jun 28, 2022 17:54 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 41,857 | $329.05 | $13,772,836.57 |
DisclosureSEC source: 0001209191-22-039569 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,161,953 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $329.00 to $329.78, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| June 24, 2022 Filed Jun 27, 2022 17:45 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 5,263 | $325.61 | $1,713,680.17 |
DisclosureSEC source: 0001209191-22-039382 · doc4.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,203,810 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $325.53 to $325.75, inclusive. Read SEC document |
| June 24, 2022 Filed Jun 27, 2022 17:45 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 113,470 | $324.97 | $36,874,345.90 |
DisclosureSEC source: 0001209191-22-039382 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,209,073 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $324.51 to $325.50, inclusive. Read SEC document |
| June 24, 2022 Filed Jun 27, 2022 17:45 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 51,387 | $324.12 | $16,655,348.89 |
DisclosureSEC source: 0001209191-22-039382 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,322,543 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $323.51 to $324.505, inclusive. Read SEC document |
| June 24, 2022 Filed Jun 27, 2022 17:45 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 30,081 | $323.06 | $9,717,907.70 |
DisclosureSEC source: 0001209191-22-039382 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,373,930 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $322.50 to $323.425, inclusive. Read SEC document |
| June 24, 2022 Filed Jun 27, 2022 17:45 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 14,799 | $321.98 | $4,765,041.22 |
DisclosureSEC source: 0001209191-22-039382 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,404,011 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $321.50 to $322.43, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4) and (5) to this Form 4. Read SEC document |
| June 23, 2022 Filed Jun 24, 2022 17:36 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 62 | $313.08 | $19,410.84 |
DisclosureSEC source: 0001209191-22-039153 · doc4.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,418,810 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $313.07 to $313.08, inclusive. Read SEC document |
| June 23, 2022 Filed Jun 24, 2022 17:36 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 83,851 | $312.41 | $26,195,555.51 |
DisclosureSEC source: 0001209191-22-039153 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,418,872 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $312.00 to $312.99, inclusive. Read SEC document |
| June 23, 2022 Filed Jun 24, 2022 17:36 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 25,526 | $311.63 | $7,954,769.48 |
DisclosureSEC source: 0001209191-22-039153 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,502,723 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $311.00 to $311.995, inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.